CD38 and acute myeloid leukemia: It is hypothesized that early leukemic hematopoietic stem and progenitor cells (HSPCs), enriched but not limited to a specific phenotype (e.g., CD34+CD38−), could be key players in AML maintenance and relapse [10,11].